in mammals it regulates neural crest (1) and vascular (2) development and plays a critical role during somitogenesis (3) . Notch also contributes to the regulation of tissue renewal in the intestine (4), skin (5) , hematopoietic system (6) , and mammary epithelium (7) . There are four Notch receptors (Notch1-4) and seven known ligands, which are Serrate/Jagged1 and 2; Delta Like1, 3, and 4 (8); Delta/ Notch-like epidermal growth factor-related receptor (9) ; and contactin/F3/NB-3 (10) . Receptors and ligands are singlepass transmembrane proteins expressed on the surface of adjacent cells. In the canonical Notch signaling pathway, Notch-ligand interactions result in the proteolytic cleavage of the extracellular region of Notch by a disintegrin and metalloproteinase domain metalloproteases, and in the subsequent cleavage within the transmembrane region of Notch by ␥-secretase (11) . Proteolysis results in the release of the Notch intracellular domain (NICD), which translocates to the nucleus (12, 13) , in which it interacts with members of the Epstein-Barr virus latency C promoter binding factor 1, suppressor of hairless and lag-1 (CSL) family of transcription factors. This interaction converts the CSL proteins from transcriptional repressors to transcriptional activators (14) , inducing the expression of hairy enhancer of split (HES) 1 or 5 (15, 16) and HES-related repressor proteins 1-3 (17) .
Wnt can activate three distinct signaling pathways, but in osteoblasts the Wnt/␤-catenin canonical pathway is used (18, 19) . In the absence of Wnt, axin, adenomatous polyposis coli, ␤-catenin, and glycogen synthase kinase (GSK)-3␤ form a complex in which ␤-catenin is phosphorylated by casein kinase-1␣ and GSK3␤, leading to ␤-catenin degradation after ubiquitination (20) . Activation of the canonical Wnt pathway leads to the inhibition of GSK3␤ and the stabilization and nuclear translocation of ␤-catenin. In the nucleus, ␤-catenin associates with members of the lymphoid enhancer binding factor-1/T cell-specific factor-4 family of transcription factors and regulates gene transcription (21) (22) (23) . Activation of Notch and Wnt canonical signaling pathways plays an important role in osteoblastogenesis. Notch and Wnt pathways interact at different levels, and Notch often, but not always, opposes Wnt/␤-catenin signaling (24 -30) .
Mesenchymal cells can differentiate into cells of various lineages, including osteoblasts, myoblasts, chondrocytes, and adipocytes (31) . The fate of mesenchymal cells and their differentiation toward cells of the osteoblastic lineage is tightly controlled by a network of extracellular and intra-cellular signals, such as bone morphogenetic proteins, Wnt/ ␤-catenin, and Notch (19, 32) . We reported that forced and constitutive expression of NICD in ST-2 stromal and MC3T3 osteoblastic cells suppresses osteoblastic differentiation (33) by inhibiting Wnt/␤-catenin signaling (34) . However, some controversy on the effect of Notch on osteoblastic maturation exists, and both inhibitory (35, 36) and stimulatory (37, 38) effects on osteoblast differentiation and function have been reported. Deletion of notch1, -2, and -3 in osteoclast precursors enhances osteoclastogenesis and bone resorption, indicating an inhibitory role of Notch on osteoclastogenesis (36) .
The intent of this study was to define the function of Notch signaling in skeletal tissue in vivo and in vitro. For this purpose, we created transgenic mice overexpressing NICD under the control of the osteoblast-specific 3.6-kb rat collagen type I promoter and determined their skeletal phenotype. An osteoblast-specific conditional deletion approach, to ablate notch1 in the adult bone environment, was also used, by crossing mice, in which notch1 sequences were flanked by lox P sites (notch1 loxP/loxP ), with transgenic mice expressing the Cre recombinase (Cre) under the control of the osteocalcin promoter. The in vivo phenotype and the phenotype of cells obtained from mice misexpressing Notch1 were examined.
Materials and Methods

Transgenic and conditional null mice
The 2.3-kb fragment coding for the murine NICD was cloned downstream of the 3.6-kb rat type I collagen promoter (39) . Microinjection of linearized DNA into pronuclei of fertilized oocytes from tropism to friend leukemia virus strain B (FVB) inbred mice (Charles River Laboratories, Wilmington, MA), and transfer of microinjected embryos into pseudopregnant mice were carried out at the Transgenic Facility of the University of Connecticut Health Center (Farmington, CT). Positive founders were identified by Southern blot analysis of tail DNA (40) and bred to wild-type FVB mice for the generation of hemizygous mice.
Transgenic Rosa notch mice, created in a hybrid 129/C57BL/6 genetic background, were obtained from D. A. Melton (Harvard University, Cambridge, MA) (41) . In these mice, the Rosa26 locus is targeted with a DNA construct encoding NICD, followed by an internal ribosome entry sequence and nuclear-localized enhanced green fluorescent protein (GFP) and preceded by a STOP cassette flanked by lox P sites. Constitutive expression of NICD from the targeted Rosa26 locus is induced after the deletion of the STOP cassette by Cre recombination of lox P sequences.
For the creation of a conditional notch1 null deletion, the notch1 locus was targeted for lox P modification, as described (42) to obtain notch1 loxP/loxP mice, which were propagated in a C57BL/6 genetic background. Cre recombination in these mice results in the removal of a 3.5-kb segment of the putative promoter of notch1 and part of the first exon encoding its signal peptide. Transgenic FVB inbred mice expressing the Cre recombinase under the control of a 3.9-kb human osteocalcin promoter (Oc-Cre) were obtained from T. 
X-ray analysis and bone histomorphometric analysis
Radiography was performed on killed 2-wk-old NICD transgenic mice on a Faxitron x-ray system (model MX 20; Faxitron x-ray Corp., Wheeling, IL). The x-rays were performed at an intensity of 30 kV for 20 sec. Static histomorphometry was carried out on femurs from experimental and control mice killed by CO 2 inhalation. Femurs were dissected, fixed in 70% ethanol, dehydrated, and embedded undecalcified in methyl methacrylate. Longitudinal sections, 5 m thick, were cut on a microtome (Microm; Richard-Allan Scientific, Kalamazoo, MI) and stained with 0.1% toluidine blue (pH 6.4) or Von Kossa. Static parameters of bone formation and resorption were measured in a defined area between 725 and 1270 m from the growth plate, using an OsteoMeasure morphometry system (Osteometrics, Atlanta, GA). The terminology and units used are those recommended by the Histomorphometry Nomenclature Committee of the American Society for Bone and Mineral Research (44) .
Cell cultures and adenoviral infection
Osteoblasts were isolated from parietal bones of 3-to 5-d-old Rosa notch or notch1 loxP/loxP mice by sequential collagenase digestion, as described (45) . Cells were cultured in DMEM (Invitrogen, Carlsbad, CA) supplemented with nonessential amino acids, 20 mm HEPES, 100 g/ml ascorbic acid, and 10% fetal bovine serum (FBS; Atlanta Biologicals, Norcross, GA) at 37 C in a humidified 5% CO 2 incubator. Bone marrow stromal cells were recovered by centrifugation of femurs that were aseptically removed from 4-wk-old Rosa notch mice, as described (46) . Cells were plated at a density of 5 ϫ 10 5 cells/cm 2 and cultured in ␣-MEM (Invitrogen) containing 15% FBS at 37 C in a humidified 5% CO 2 incubator.
At subconfluence, stromal cells or osteoblasts were transferred to either ␣-MEM or DMEM containing 2% FBS for 1 h before exposure overnight to 100 multiplicity of infection of replication defective recombinant adenoviruses (Ad). To induce recombination of the lox P sequences, an adenoviral vector expressing Cre recombinase under the control of the cytomegalovirus (CMV) promoter (Ad-CMV-Cre) (Vector Biolabs, Philadelphia, PA) was transduced. An adenoviral vector expressing GFP under the control of the CMV promoter (Ad-CMV-GFP) (Vector Biolabs) was used as a control. Cells were washed in versene (Invitrogen), and stromal cells or osteoblasts were cultured in the presence of either ␣-MEM or DMEM containing 10% FBS. Recombination of lox P sequences was tested by Southern blot analysis in Rosa notch cell cultures.
RNA interference
To down-regulate Notch2 expression in vitro, a 19-mer doublestranded small interfering (si) RNA targeted to bp 1965-1983 of the Notch2 mouse mRNA sequence was obtained commercially, and a scrambled 19-mer siRNA with no homology to known mouse or rat sequences was used as control (Ambion, Austin, TX) (47, 48) . Notch2 or scrambled siRNA, both at 20 nm, was transfected into subconfluent notch1 loxP/loxP osteoblasts after transduction with Ad-CMV-GFP or Ad-CMV-Cre to delete notch1, using siLentFect lipid reagent, in accordance with the manufacturer's instructions (Bio-Rad, Hercules, CA). Cells were allowed to recover for 24 h before the determination of alkaline phosphatase activity (APA). To ensure adequate down-regulation, total RNA was extracted in parallel cell cultures 96 h after the transfection of siRNAs and Notch2 mRNA levels determined by real time RT-PCR.
APA
To determine the effects of Notch1 on APA, Rosa notch stromal cells and osteoblasts or notch1 loxP/loxP osteoblasts, transduced with Ad-CMV-GFP or Ad-CMV-Cre, were cultured in the presence of 100 g/ml ascorbic acid and 5 mm ␤-glycerophosphate (Sigma-Aldrich, St. Louis, MO) and treated with recombinant bone morphogenetic protein (BMP)-2 (Wyeth, Collegeville, PA) or Wnt 3a (R&D Systems, Minneapolis, MN) for 72 h and harvested. APA was determined in 0.5% Triton X-100 cell extracts by the hydrolysis of p-nitrophenyl phosphate to p-nitrophenol and measured by spectroscopy at 405 nm after 10 min of incubation at room temperature, according to the manufacturer's instructions (Sigma-Aldrich). Data are expressed as nanomoles of p-nitrophenol released per minute per microgram of protein. Total protein content was determined in cell extracts by the DC protein assay, in accordance with the manufacturer's instructions (Bio-Rad).
Real-time RT-PCR
Total RNA was extracted from cell cultures after transduction with Ad-CMV-GFP or Ad-CMV-Cre and mRNA levels determined by realtime RT-PCR (49, 50) . For this purpose, 5 g of total RNA were reverse transcribed using SuperScript III platinum two-step quantitative RT-PCR kit (Invitrogen), according to the manufacturer's instructions and amplified in the presence of 5Ј-CGGTTAGGGCGTCTCCACAGTAAC- 
Western blot analysis
To assess the effects of NICD overexpression on cytosolic ␤-catenin levels or signaling mother against decapentaplegic (Smad) 1/5/8 phosphorylation, Rosa notch stromal cells, after transduction with Ad-CMV-GFP or Ad-CMV-Cre, were serum deprived overnight and exposed to control medium, Wnt 3a for 16 h, or BMP-2 for 20 min. To determine cytosolic ␤-catenin levels, the cell layer was washed in PBS and extracted in 10 mm Tris, 140 mm NaCl, 5 mm EDTA, and 2 mm dithiothreitol buffer (pH 7.6) in the presence of protease inhibitors and the cytosolic fraction separated by ultracentrifugation, as described (54) . Twenty micrograms of total cytosolic protein were fractionated by gel electrophoresis in 7.5% polyacrylamide gels and transferred to Immobilon P membranes (Millipore, Billerica, MA). The membranes were blocked with 3% BSA in PBS and exposed to a 1:500 dilution of a monoclonal antibody to unphosphorylated ␤-catenin (Santa Cruz Biotechnology, Santa Cruz, CA) or exposed to a 1:1000 dilution of a goat polyclonal antibody to actin (Santa Cruz Biotechnology). To determine the level of Smad 1/5/8 phosphorylation, the cell layer was washed in PBS and extracted in cell lysis buffer (Cell Signaling Technology, Beverly, MA) in the presence of protease and phosphatase inhibitors. Protein concentrations were determined using a DC protein assay kit (Bio-Rad), and 20 g of total cellular protein were fractionated by electrophoresis in 10% polyacrylamide gels and transferred to Immobilon P membranes. The membranes were blocked with 3% BSA in PBS and exposed to a rabbit polyclonal antibody, which recognizes Smad 1/5/8 phosphorylated at carboxylterminal serine residues (Cell Signaling Technology) or exposed to a mouse monoclonal antibody to unphosphorylated Smad 1 (Santa Cruz Biotechnology) at a 1:1000 dilution. All blots were exposed to antirabbit or antimouse IgG antiserum conjugated to horseradish peroxidase and developed with a chemiluminescence detection reagent (PerkinElmer, Waltham, MA).
Transient transfections
To determine changes in Notch signaling in Rosa notch , calvarial osteoblasts, transduced with Ad-CMV-Cre or Ad-CMV-GFP, were transfected with a construct containing six multimerized dimeric CSL binding sites, linked to the ␤-globin basal promoter (12xCSL-Luc; L. J. Strobl, Institute for Clinical Molecular Biology, Munich, Germany), or a 354-bp fragment of the HES1 promoter (HES1-Luc; U. Lendahl, Karolinska Institute, Stockholm, Sweden), both cloned upstream of the luciferase reporter gene (55) (56) (57) (58) . Transient transfections were conducted in Rosanotch osteoblasts cultured to 70% confluence using FuGene6 (3 l FuGene6/2 g DNA), according to the manufacturer's instructions (Roche, Indianapolis, IN). A CMV-directed ␤-galactosidase expression construct (CLONTECH, San Jose, CA) was used to control for transfection efficiency. Cells were exposed to the FuGENE6-DNA mix for 16 h, transferred to ␣-MEM containing 10% FBS for 24 h, and harvested. Luciferase and ␤-galactosidase activities were measured using an Optocomp luminometer (MGM Instruments, Hamden, CT). Luciferase activity was corrected for ␤-galactosidase activity.
Statistical analysis
Data are expressed as means Ϯ sem. Statistical differences were determined by ANOVA or Student's t test.
Results
Type I collagen transgenic mice
Three founder mice overexpressing NICD under the control of the 3.6-kb rat type I collagen promoter were identified. One founder had a total of five litters, but none of the born pups carried the transgene. A second founder had only one litter containing two pups carrying the transgene, and both died unexpectedly at 2 wk of age. A third founder had five litters and a total of four mice carried the transgene, which died between 3 and 4 wk of age but were available for analysis. Because of the early death of NICD transgenics, appropriate transgenic lines could not be established. However, we were able to perform a limited number of observations on the hemizygous mice available. Hemizygous NICD transgenic mice were compared with WT littermate controls at 3-4 wk of age. Contact radiography of the skeleton revealed that transgenic mice were smaller than WT controls and appeared osteopenic (Fig. 1A) . Bone histomorphometric analysis of distal femurs from 3-to 4-wk-old hemizygous NICD transgenics revealed an 80% decrease in bone volume per tissue volume, due to a reduced number of trabeculae (Table 1 and Fig. 1B) . The observed decrease in bone volume was associated with a reduction in the number of osteoblasts per tissue area, number of osteoblasts per bone perimeter, and osteoblast surface per bone surface (Table 1 and Fig. 1C) . Although the number of osteoclasts per tissue area was decreased because of the lesser number of trabeculae, the number of osteoclasts per bone perimeter and osteoclast surface per bone surface were not different from controls (Table 1) .
NICD overexpression in vitro
Because the founder mice and the first generation of NICD transgenics died before the establishment of transgenic lines, the impact of NICD overexpression on osteoblastic cell function was investigated in cells from Rosa notch mice, in which a STOP cassette, between the Rosa26 promoter and the NICD coding sequence, is flanked by lox P sites. Bone marrow stromal cells and calvarial osteoblasts from Rosa notch mice were cultured and transduced with an adenoviral vector expressing recombinant Cre under the control of the CMV promoter (Ad-CMV-Cre) to induce NICD expression or with a control vector in which the CMV promoter drives the expression of GFP (Ad-CMV-GFP). Effective recombination of lox P sequences and removal of the STOP cassette was documented by Southern blot analysis of cellular DNA; recombination was detected in cells transduced with Ad-CMV-Cre and not in control cells transduced with Ad-CMV-GFP ( Fig. 2A) . Confirming the overexpression of Notch, Rosa notch stromal cells transduced with Ad-CMV-Cre expressed Notch1 transcripts that were 6-fold greater than that in Ad-CMV-GFPtransduced cells (Fig. 2C) . Accordingly, Ad-CMV-Cre-transduced cells expressed mRNA levels of the Notch target hes1 that were 16-fold greater than in Ad-CMV-GFP transduced cells. After 3 d of culture, NICD-overexpressing cultures exhibited suppressed APA. Furthermore, Notch decreased the stimulatory effects of BMP-2 and Wnt 3a on APA (Fig. 2B) . Accordingly, alkaline phosphatase and osteocalcin mRNA levels were suppressed in Rosa notch marrow stromal cells overexpressing NICD, confirming its inhibitory effect on osteoblastic differentiation (Fig. 2C) . To examine possible mechanisms underlying the decreased osteoblastic differentiation in Ad-CMV-Cre transduced Rosa notch stromal cells, we tested whether NICD overexpression affected BMP/Smad or Wnt/␤-catenin signaling. Confirming previous studies (34), BMP-2 induced Smad 1/5/8 phosphorylation, but NICD overexpression did not modify the effect of BMP-2 on Smad 1/5/8 phosphorylation (not shown), whereas NICD overexpression decreased the levels of cytosolic ␤-catenin and opposed the stimulatory effect of Wnt 3a on cytosolic ␤-catenin levels (Fig. 2D) .
In preliminary experiments, we were unable to transfect reporter constructs with sufficient efficiency into bone marrow stromal cells. Consequently, to perform these experiments and confirm the results observed in stromal cells, calvarial osteoblasts from Rosa notch mice were isolated and transduced with Ad-CMV-Cre to induce NICD overexpression or with Ad-CMV-GFP to be used as control. Cre recombination of lox P sequences was confirmed by Southern blot analysis (Fig. 3A) ; Notch1 overexpression was confirmed by real-time RT-PCR, and Notch1 transcripts were 2.5-fold greater in Ad-CMV-Cre transduced cells than that in control Ad-CMV-GFP cells (Fig. 3D) . To confirm the activation of Notch signaling, cells were transfected with a 12xCSL-Luc Notch reporter construct or with HES1-Luc, a fragment Bone histomorphometry was performed on femurs from 3-to 4-wk-old NICD hemizygous mice and littermate WT controls. Values are pooled from three litters and are expressed as means Ϯ SEM; n ϭ 4 -5.
a Significantly different from WT controls, P Ͻ 0.05. osteoblasts overexpressing Notch1 exhibited decreased levels of APA when compared with control cells cultured with vehicle, BMP-2, or Wnt 3a (Fig. 3C) . Osteocalcin mRNA levels were decreased in Ad-CMV-Cre-transduced osteoblasts (Fig. 3D) , confirming that NICD overexpression impairs osteoblastic differentiation.
Notch1 conditional null mice
Bone histomorphometry revealed that notch1 loxP/loxP homozygous mice were not different from WT littermate controls ( Table 2 (Fig. 4A) . Bone histomorphometric analysis of femurs from 4-wk-old female notch1 ⌬/⌬ revealed that they were not different from controls (Table 3 and Fig. 4B) , except for an increase in eroded surface per bone surface and osteoclast surface per bone surface; a nonsignificant increase in osteoclast number per perimeter and per area was also noted (Table 3) . Four-week-old male notch1 ⌬/⌬ mice did not exhibit a skeletal phenotype when compared with notch1 loxP/loxP male littermate controls (not shown).
Notch1 deletion in vitro
We hypothesized that the lack of a phenotype in notch1 ⌬/⌬ mice was secondary to the rescue of Notch activity by notch2. Because a double notch1, notch2 conditional null mouse was not readily available to our laboratory at the time the studies were conducted, Notch2 expression was down-regulated in vitro in the context of the notch1 deletion to assess the function of Notch in osteoblasts. Notch1 loxP/loxP calvarial osteoblasts were transduced with Ad-CMV-Cre to ablate notch1 expression, whereas notch2 was down-regulated by RNA interference. The expression of Notch1 and Notch2 mRNA was suppressed in these cells (Fig. 5A) . Notch1 loxP/loxP calvarial osteoblasts transduced with Ad-CMV-Cre and transfected with Notch2 siRNA exhibited increased levels of APA after treatment with BMP-2, Wnt 3a, or control vehicle, compared with Ad-CMV-GFP-transduced cells transfected with scrambled siRNA (Fig. 5B) . Thus, removal of Notch signaling in vitro causes an increase in APA in calvarial osteoblasts, which is in accordance with the suppressive effects of NICD overexpression on APA observed in Rosa notch calvarial osteoblasts and stromal cells.
Discussion
Our results demonstrate that transgenic mice overexpressing NICD under the control of the 3.6-kb rat type I collagen pro- Eroded surface/bone surface (%) 23.5 Ϯ 1.7 24.7 Ϯ 1.9
Bone histomorphometry was performed on femurs from 4-wk-old notch1 loxP/loxP female mice and WT littermate controls. Values are means Ϯ SEM; n ϭ 7.
moter exhibit osteopenia and impaired growth when compared with control WT mice of the same age and genetic composition. The decrease in bone volume and trabecular number appears to be secondary to a decrease in osteoblast number. This is possibly secondary to an inhibition of cell differentiation caused by Notch, which would maintain cells of the osteoblastic lineage in an undifferentiated state. An increase in apoptosis could cause a decrease in osteoblast number, but no increase in cell death was detected in femoral sections of Notch transgenics when examined by the terminal uridine deoxynucleotidyl transferase deoxyuridine 5-triphosphate nick end labeling reaction (data not shown). Regrettably, the early death of NICD transgenics precluded the full establishment of a transgenic line and the study of dynamic parameters of bone histomorphometry.
We suspect intrauterine lethality of NICD transgenics because only six transgenics were born from 11 litters. The cause of the intrauterine loss was not established, but if embryonic death occurred, it could have been related to a developmental impact of Notch in nonskeletal tissues (1-3) . The 3.6-kb type I collagen promoter is activated at d 14 of embryonic life, and its expression is not entirely specific to skeletal cells (39) . Although this fragment of the type I collagen promoter is commonly used for the study of gene expression in osteoblastic cells and the skeletal phenotype of Notch transgenics is pronounced, one cannot exclude that the impaired growth observed in Notch1 transgenics is due to a runting effect or nonspecific effects secondary to Notch expression in various connective tissues. Recently impaired osteoblast maturation was reported in transgenics in which NICD expression was under the control of a 2.3-kb fragment of the type I collagen promoter (59). Lethality was not reported when Notch was expressed under the control of the 2.3-kb type I collagen fragment, possibly because this fragment is less active and more specific to osteoblasts than the 3.6-kb type I collagen fragment (39) . It is of interest that 2.3-kb type I collagen NICD transgenics showed increased bone volume, and the tissue was composed of immature woven bone, secondary to the presence of immature osteoblasts (59). The differences in the phenotypes reported can be explained by the differential activation of the 2.3-and 3.6-kb fragment of the type I collagen promoter, resulting in the arrest of osteoblastic cell differentiation at different stages of maturation (39) . It is possible that NICD overexpression under the control of the 2.3-kb type I collagen promoter represses the terminal differentiation of osteoblasts and allows for the proliferation of immature cells, leading to the increased formation of woven bone and the reported phenotype (59) . In contrast, NICD overexpression under the control of the 3.6-kb type I collagen promoter would repress osteoblastogenesis at an earlier stage of cell differentiation, leading to a decreased number of mature osteoblasts and an osteopenic phenotype.
Expression of Notch1 under the control of the osteocalcin promoter was attempted to determine Notch activity in mature osteoblasts, but mice exhibited newborn lethality secondary to hydrocephalus, most likely due to osteocalcin expression and Notch activation in the central nervous system (60) . Postnatal activation of NICD in mature osteoblasts using Rosa notch was attempted by mating Rosa notch mice with mice expressing a tamoxifen inducible Cre estrogen receptor type 2 fusion protein, under the control of the 2.3-kb type I collagen promoter (61) . However, the administration of tamoxifen inhibited bone turnover and reduced osteoblast and osteoclast number, eroded surface, and bone formation, thereby obscuring a potential Notch phenotype (data not shown).
The conditional deletion of notch1 in mature osteoblasts in vivo did not cause an obvious skeletal phenotype. This could (33) , indicating an inhibition of osteoblastogenesis. Accordingly, NICD overexpression in primary cultures of stromal cells and calvarial osteoblasts from Rosa notch mice caused a suppression of APA and a reduction in osteocalcin mRNA levels. Conversely, in vitro experiments in calvarial osteoblasts in conditions of notch1 and notch2 suppression caused an increase in APA. The observation confirms studies in mammalian nonskeletal cells, in which NICD interacts with runt-related transcription factor-2 and represses the transactivation of an osteocalcin reporter construct (59, 64) .
Our findings corroborate the notion, proposed in previous studies by our group and others (33) (34) (35) (36) , that Notch inhibits osteoblastogenesis. However, transient stimulation of Notch signaling can sensitize osteoblastic cell lines to selected effects of BMP-2 (37, 38) , and interference with Notch activity by the use of a ␥-secretase inhibitor prevents a stimulatory effect of BMP-2 on APA in MC3T3 osteoblastic cells (37) . The exact reason for the discrepancies is not clear, although they could be explained by the use of different cells, time of cellular exposure to Notch, and experimental approaches. Notch could play a dual stimulatory and inhibitory role during osteoblastogenesis. A dual role for Notch has been proposed in the chondrogenic differentiation of human bone marrow stromal cells, in which Notch signal activation induced by Jagged1 is necessary for the early phases of chondrogenesis, but Jagged1 needs to be down-regulated to allow for differentiation to continue (65) .
Although Notch increased hes1 transcript levels and hes1 promoter activity in calvarial osteoblasts, other Notch target genes may be responsible for the effect of Notch on osteoblastogenesis. Further investigations are needed to clarify the role of HES1 in osteoblastogenesis because the effects of HES1 do not always recapitulate those of Notch in cells of mesenchymal origin (66) . Furthermore, different targets of Notch signaling could be involved in mediating the effects of Notch on osteoblastogenesis, and HES-related repressor proteins 2, an alternate Notch effector, is known to inhibit osteoblastic differentiation (35) . In addition, there is evidence of Notch autoregulation in bone marrow stromal cells and calvarial osteoblasts. NICD overexpression in cells from Rosa notch mice caused a 50 -90% suppression of Notch2 mRNA levels (data not shown). This could represent down-regulation of notch2 by notch1 or possibly a negative feedback loop leading to a generalized suppression of Notch expression after the activation of the Notch signaling cascade. As expected, Notch1 mRNA levels were not repressed because its transcription was under the control of the Rosa26 promoter.
In previous work, we have shown that NICD overexpression inhibits osteoblastogenesis by opposing canonical Wnt/␤-catenin signaling (34) . These results were confirmed in bone marrow stromal cells from Rosa notch mice overexpressing NICD, which exhibited reduced basal and Wnt 3a-induced cytosolic ␤-catenin levels. Because the canonical Wnt signaling pathway is necessary for bone development and the regulation of bone mass (19) , the opposing action of Notch on this pathway supports the role of Notch signaling as a suppressor of osteoblastogenesis. These observations are in accordance with studies in nonosteoblastic cells, demonstrating cross talk between Notch and Wnt pathways (24 -30) .
In conclusion, our results demonstrate that Notch inhibits osteoblastogenesis, causing osteopenia, possibly by inhibiting the Wnt/␤-catenin pathway.
